Hrt Financial LP Iovance Biotherapeutics, Inc. Transaction History

Hrt Financial LP

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$7.78 - $14.19 $1.75 Million - $3.2 Million	-225,207 Reduced 76.04%	70,967 $569,000
Q1 2024 May 13, 2024	BUY	$7.59 - $17.47 $10,709 - $24,650	1,411 Added 0.48%	296,174 $4.39 Million
Q4 2023 Feb 09, 2024	BUY	$3.3 - $8.89 $972,717 - $2.62 Million	294,763 New	294,763 $2.4 Million
Q1 2023 May 12, 2023	BUY	$5.53 - $8.22 $1.48 Million - $2.2 Million	267,997 New	267,997 $1.64 Million
Q3 2022 Nov 14, 2022	BUY	$9.53 - $13.11 $1.33 Million - $1.83 Million	139,467 New	139,467 $1.34 Million
Q2 2022 Aug 12, 2022	SELL	$6.38 - $18.33 $1.36 Million - $3.9 Million	-212,974 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$12.38 - $19.1 $1.83 Million - $2.82 Million	147,460 Added 225.08%	212,974 $3.55 Million
Q4 2021 Feb 14, 2022	SELL	$16.55 - $27.63 $102,444 - $171,029	-6,190 Reduced 8.63%	65,514 $1.25 Million
Q3 2021 Nov 15, 2021	BUY	$20.35 - $26.63 $1.46 Million - $1.91 Million	71,704 New	71,704 $1.77 Million
Q1 2021 May 17, 2021	SELL	$28.67 - $52.59 $2.32 Million - $4.26 Million	-80,965 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$28.04 - $50.26 $2.27 Million - $4.07 Million	80,965 New	80,965 $3.76 Million
Q3 2020 Nov 13, 2020	SELL	$27.75 - $36.3 $3.11 Million - $4.07 Million	-112,098 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$27.21 - $41.0 $3.05 Million - $4.6 Million	112,098 New	112,098 $3.08 Million

314

241M

3.77M

1.7M

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $1.35B
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.